266 related articles for article (PubMed ID: 22138492)
1. Functionalized nanosystems for targeted mitochondrial delivery.
Durazo SA; Kompella UB
Mitochondrion; 2012 Mar; 12(2):190-201. PubMed ID: 22138492
[TBL] [Abstract][Full Text] [Related]
2. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
3. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.
Moreira PI; Cardoso SM; Pereira CM; Santos MS; Oliveira CR
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):492-511. PubMed ID: 19702564
[TBL] [Abstract][Full Text] [Related]
5. Functionalized and Nonfunctionalized Nanosystems for Mitochondrial Drug Delivery with Metallic Nanoparticles.
Misra SK; Rosenholm JM; Pathak K
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375256
[No Abstract] [Full Text] [Related]
6. Nanoparticle-based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease.
Suzuki I; Xing H; Giblin J; Ashraf A; Chung EJ
J Biomed Mater Res A; 2024 Jun; 112(6):895-913. PubMed ID: 38217313
[TBL] [Abstract][Full Text] [Related]
7. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial therapeutic interventions in Alzheimer's disease.
Van Giau V; An SSA; Hulme JP
J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer's disease.
Ding XW; Robinson M; Li R; Aldhowayan H; Geetha T; Babu JR
Pharmacol Res; 2021 Sep; 171():105783. PubMed ID: 34302976
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
[TBL] [Abstract][Full Text] [Related]
12. DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
Weissig V
Methods Mol Biol; 2015; 1265():1-11. PubMed ID: 25634263
[TBL] [Abstract][Full Text] [Related]
13. Triphenylphosphonium Decorated Liposomes and Dendritic Polymers: Prospective Second Generation Drug Delivery Systems for Targeting Mitochondria.
Paleos CM; Tsiourvas D; Sideratou Z
Mol Pharm; 2016 Jul; 13(7):2233-41. PubMed ID: 27280339
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
15. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
16. Targeting drugs to mitochondria.
Heller A; Brockhoff G; Goepferich A
Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
[TBL] [Abstract][Full Text] [Related]
17. In Vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel.
Solomon MA; Shah AA; D'Souza GG
Mitochondrion; 2013 Sep; 13(5):464-72. PubMed ID: 23123917
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
Cunha S; Amaral MH; Lobo JM; Silva AC
Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
[TBL] [Abstract][Full Text] [Related]
19. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
[TBL] [Abstract][Full Text] [Related]
20. Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.
Brenza TM; Ghaisas S; Ramirez JEV; Harischandra D; Anantharam V; Kalyanaraman B; Kanthasamy AG; Narasimhan B
Nanomedicine; 2017 Apr; 13(3):809-820. PubMed ID: 27771430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
